In 2017 the Raskatov lab introduced the oligomer-to-fibril conversion paradigm, “Chiral Inactivation”, as a strategy to block neurotoxic actions of Aβ using mirror image peptides. The ensuing mechanistic research led the lab to the “rippled” beta sheet: a structural class predicted by Linus Pauling and Robert Corey of CalTech in 1953 and largely forgotten since. From 2022 onwards, (69 years later!), the Raskatov lab put the rippled sheet on a firm experimental foundation.